Search
Vilaprisan
go.drugbank.com/drugs/DB11971InvestigationalVilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.
Golvatinib
go.drugbank.com/drugs/DB11977InvestigationalGolvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
Categories: Heterocyclic Compounds, 1-Ring, Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitorsLetaxaban
go.drugbank.com/drugs/DB11984InvestigationalLetaxaban has been used in trials studying the treatment and prevention of Venous Thromboembolism and Acute Coronary Syndrome.
Categories: Heterocyclic Compounds, 1-RingDapaconazole
go.drugbank.com/drugs/DB11985InvestigationalDapaconazole has been used in trials studying the treatment of Tinea Pedis.
Categories: Heterocyclic Compounds, 1-RingGSK-2018682
go.drugbank.com/drugs/DB11987InvestigationalGSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingPF-03463275
go.drugbank.com/drugs/DB11993InvestigationalPF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments Associated With Schizophrenia.
Categories: Heterocyclic Compounds, 1-RingInterleukin-7
go.drugbank.com/drugs/DB11997InvestigationalInterleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
Synonyms: SH-polypeptide-42, IL-7Sorivudine
go.drugbank.com/drugs/DB11998InvestigationalSorivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.
Categories: Heterocyclic Compounds, 1-RingPrexasertib
go.drugbank.com/drugs/DB12008InvestigationalPrexasertib has been used in trials studying the treatment and basic science of mCRPC, Leukemia, Neoplasm, breast cancer, and Ovarian Cancer, among others.
Categories: Heterocyclic Compounds, 1-RingPonesimod
go.drugbank.com/drugs/DB12016ApprovedInvestigational[A232079] Fingolimod's activity at sphingosine 1-phosphate receptor 3 was suspected to be responsible for a portion of it's adverse effects, and so more selective modulators were developed. … Ponesimod is a selective sphingosine 1-phosphate receptor 1 modulator indicated in the treatment of relapsing forms of multiple sclerosis in adults.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates